These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24699498)

  • 1. Patient management problem.
    Kelly AG
    Continuum (Minneap Minn); 2014 Apr; 20(2 Cerebrovascular Disease):476-81, 482-93. PubMed ID: 24699498
    [No Abstract]   [Full Text] [Related]  

  • 2. Stroke research priorities for the next decade--A representative view of the European scientific community.
    Meairs S; Wahlgren N; Dirnagl U; Lindvall O; Rothwell P; Baron JC; Hossmann K; Engelhardt B; Ferro J; McCulloch J; Kaste M; Endres M; Koistinaho J; Planas A; Vivien D; Dijkhuizen R; Czlonkowska A; Hagen A; Evans A; De Libero G; Nagy Z; Rastenyte D; Reess J; Davalos A; Lenzi GL; Amarenco P; Hennerici M
    Cerebrovasc Dis; 2006; 22(2-3):75-82. PubMed ID: 16790993
    [No Abstract]   [Full Text] [Related]  

  • 3. Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke.
    Essig F; Kollikowski AM; Müllges W; Stoll G; Haeusler KG; Schuhmann MK; Pham M
    JAMA Neurol; 2021 May; 78(5):615-617. PubMed ID: 33683294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of acute ischemic stroke.
    Leira EC; Adams HP
    Clin Geriatr Med; 1999 Nov; 15(4):701-20. PubMed ID: 10499931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteplase for ischaemic stroke.
    Burrage D
    Lancet; 2014 Oct; 384(9953):1502. PubMed ID: 25390573
    [No Abstract]   [Full Text] [Related]  

  • 7. Alteplase for ischaemic stroke--responses.
    Hudson I
    Lancet; 2014 Aug; 384(9944):662-3. PubMed ID: 25152268
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteplase for ischaemic stroke--responses.
    Wardlaw JM; Murray V; Berge E; Del Zoppo GJ
    Lancet; 2014 Aug; 384(9944):661-2. PubMed ID: 25152267
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteplase for ischaemic stroke--responses.
    Sandercock P; Lindley R; Wardlaw JM; Murray G; Whiteley W; Cohen G
    Lancet; 2014 Aug; 384(9944):660-1. PubMed ID: 25152266
    [No Abstract]   [Full Text] [Related]  

  • 10. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused.
    Davis SM; Hand PJ; Donnan GA
    Med J Aust; 2007 Nov; 187(10):548-9. PubMed ID: 18021039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
    Hoffman JR
    Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Liao X; Wang Y; Wang Y
    Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Coutts SB; Hill MD
    Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
    [No Abstract]   [Full Text] [Related]  

  • 15. MRI-assisted thrombolysis for delayed arrival among patients with ischemic stroke.
    Khatri R; Miley JT; Qureshi AI
    J Neuroimaging; 2011 Oct; 21(4):307-8. PubMed ID: 21121999
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Chao AC; Po HL; Chan L
    Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Behrouz R; Mutgi SA; Silver B
    Stroke; 2015 Jun; 46(6):e149. PubMed ID: 25899241
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Bruno A; Switzer JA
    Neurology; 2012 Jul; 79(5):486-7; author reply 486-7. PubMed ID: 22851721
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Kent TA
    Neurology; 2012 Apr; 78(17):1368. PubMed ID: 22529207
    [No Abstract]   [Full Text] [Related]  

  • 20. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.